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Abstract 
The gold standard for the classification of lupus nephritis (LN) is renal histology but reporting variation exists. The aim of this study was to assess the inter-observer variability of the 2003 International Society Nephrology/Royal Pathology Society (ISN/RPS) LN histological classification criteria in children. Histopathologists from a reference centre and three tertiary pediatric centres independently reviewed digitalized renal histology slides from 55 children with LN. Histological ISN/RPS Class was assigned and features scored; LN-activity [scored 0-24], LN-chronicity [0-12], and tubulointerstitial (TIA) activity [0-21]. In the cohort (73% females) the age at the time of biopsy was 15.5+0.39 (mean+standard error) years. Based on the reference centre, 42% (23/55) had ISN/RPS Class IV with LN-activity score 4.23+0.50, LN-chronicity 1.81+0.18, and TIA 4.45+0.35. There were 4-54 (mean 16.7) glomeruli per biopsy. Pathologists had fair agreement for ISN/RPS assignment (kappa; 0.26+0.12), LN-chronicity (intra-class correlation ICC 0.36+0.09 and TIA (0.22 + 0.09) scores. There was good agreement for LN-activity scores (ICC 0.69+0.06). When categorized into proliferative and non-proliferative disease, poor agreement among sites remained (kappa 0.24+0.11). Despite unified criteria for the interpretation of histological features of LN, marked reporting variation remains in clinical practice. As proliferative LN is managed more intensively, this may influence renal outcomes. 



Introduction
Systemic lupus erythematosus (SLE) is a life-long autoimmune disease. Disease onset during childhood and adolescence constitutes approximately 15-20% of all cases, and these patients often experience greater disease severity and more pronounced organ manifestations when compared to the adult-onset SLE  ADDIN EN.CITE (, ). As such lupus nephritis (LN) is quite common with SLE onset early in life  ADDIN EN.CITE (). Despite immunosuppressive treatment, progression to chronic kidney disease occurs in 22% of adult patients with biopsy proven LN  ADDIN EN.CITE (). Furthermore, studies have shown that LN is an independent risk factor to increased mortality in both children and adults  ADDIN EN.CITE ().
Active LN can present with a spectrum of clinical signs that include variable levels of proteinuria, haematuria, urine sediment, and even renal failure (). Due to its variable clinical presentation, the gold standard for diagnosis and classification of LN is based on kidney histology. Accurate LN histological grading is important as it informs clinical treatment, especially the use of traditional and biological immunosuppressives  ADDIN EN.CITE (). 
Internationally agreed classification systems were first published by the World Health Organisation (WHO) in 1974, modified in 1982 and revised in 1995 (). These Criteria were developed with the intent to improve communication between clinicians and pathologists and to allow comparison between patients to guide diagnostic and prognostic studies  ADDIN EN.CITE (). Following advancement in the knowledge of the pathogenesis and clinical outcomes of LN, a revised scoring system was formulated in 2003 by the International Society of Nephrology (ISN) and Renal Pathology Society (RPS)  ADDIN EN.CITE (). Earlier studies suggest that there continues to be marked variation in the interpretation of LN histology in adult-onset LN  ADDIN EN.CITE (). Studies in children are important as the histological interpretation may only be performed at baseline and relies on a small biopsy sample size due to their anatomical size and the use of smaller gauge needles . This has the potential to result in additional  variations among pathologists in their interpretation of specimens . 
Hence, the objective of this study was to investigate the inter-pathologist agreement when interpreting kidney biopsies from children and adolescents with LN, focusing on 2003 ISN/RPS histological class assignment, grading of LN-activity and chronicity as well as tubular interstitial features.

Patients and Methods	
Renal biopsy specimens 
A random sample of 58 patients who met the criteria for the American College of Rheumatology (ACR) SLE prior to age 18 years () were included in this study. All patients had required a kidney biopsy as part of clinical care. Histology slides were scanned in their entirety using Aperio Systems (Aperio eSlide manager by Leica Biosystems Ltd; www.aperio.com (​http:​/​​/​www.aperio.com​)) for subsequent interpretation by expert paediatric nephropathologists. The study was an evaluation of the anonymous clinical re-interpretation of US histology slides; therefore ethical approval was not required in accordance with National Health Service (NHS) regulatory authority guidelines. The study was approved by the institutional review boards of the participating U.S. site.
Histopathologists
Four paediatric histopathologists from four tertiary medical centres caring for children and adolescents with LN in the U.S. and the United Kingdom were approached to take part in this study. One centre was randomly designated as the reference centre. Participating nephropathologists were usually responsible for interpreting kidney histology and generating LN biopsy reports in their centre. Each centre had one reader and each other centre was allocated a code, centre x, y and z. All included biopsies were interpreted by the reference centre plus at least one other centre. 
The participating histopathologists independently reviewed the histology slides, were blinded to each other’s interpretation of the biopsy specimens, and to the clinical data of each of the patients. Cases were assigned in numerical order to the centres. Histopathologists were also asked to indicate if they felt a case’s interpretation was limited for any reason, such as the quality of the histology slide or a technical reason with the digital system. 

Histology Scoring
Using a standardized data collection form, nephropathologists were asked to rate a given case according to the ISN/RPS classification. Histological specimens that were reported as mixed Classes (III/V or IV/V) by the reference centre, were considered to have proliferative LN (defined as Class III/IV) for the purpose of our analysis. Further, the nephropathologists provided information about features of activity, chronicity and renal tubulointerstitial appearances with details provided below.
LN activity Index.  Histological features of LN activity were; glomerular proliferation (endocapillary hypercellularity), karyorrhexis (fibrinoid necrosis), leucocyte exudation, cellular crescents, subendothelial deposits (wireloops) and interstitial inflammation. As previously suggested  ADDIN EN.CITE (, ), each of these features was included in the LN-activity index and given a numerical score of 0, 1, 2, or 3, depending on the extent of involvement; in this context an item score of 0 signifies that a given feature is absent, a score of 1 is given if <25% of the glomeruli are affected, a score of 2 is given if 25-50% glomeruli are involved, and a score of 3 if the feature was present in >50% of glomeruli. The LN-Activity summary score consists of the sum of the numeric item scores, with scores for karyorrhexis and cellular crescents given a weight of 2, producing a potential maximum LN activity score of 24. 
LN-Chronicity Index. As done in the past (), LN damage assessment includes glomerular sclerosis, fibrous crescents, interstitial fibrosis and tubular atrophy. Item scores of 0 reflects absence of a given item included in the LN Chronicity score, a score of 1 was given if <25% of the region is affected, a score of 2 suggests that 25-50% of the glomeruli are affected and a score of 3 if the feature is present in >50% of them. The LN-Chronicity Index summary score consists of the sum of the item scores, resulting in a maximum possible LN-Chronicity score of 12. 
Tubulointerstitial activity Index. As previously suggested, when assessing tubulointerstitial activity (TIA) we considered  ADDIN EN.CITE (, , ); tubular cell pyknosis, tubular cell activation, tubular cell necrosis, tubular cell flattening, tubular macrophages, tubular epithelial cells and interstitial inflammation.  Each of these features were given scores between 0 and 3, depending on the extent of involvement; a score of 0 represents the absence of a given feature, score of 1 was given if <25% of the tubulointerstitial (TI) region was affected; a score of 2 and 3 with involvement of 25-50% and >50% of the tubulointerstitial region The TIA index summary scores can range from 0 (no interstitial activity) to a potential maximum score of 21. 
Statistical analysis
Demographic data were summarized using mean values with standard error values (SE). Mean scores from the LN activity, LN chronicity and TIA indices, respectively, were compared between centres as well as differences among centres in declaring degenerative changes (LN-chronicity score 0 vs. >1) and interstitial involvement (TIA score 0 vs. >1) to be present or not.  
For the ISN/RPS biopsy classes, inter-centre agreement was estimated using Kappa statistics. Intra-class correlations [ICC (3,1)] were calculated to estimate inter-centre agreement of LN-activity, LN-chronicity and TIA. Both for the kappa and ICC statistics agreement between each of the centres x,y,z with the reference centre was determined as well as overall agreement among all readers. 
In secondary analysis we attempted to assess the clinical implications of the variation among nephropathology reporting. In that we assessed differences in the assignment of a diagnosis of proliferative LN (Class III and IV with or without overlapping membranous changes) in the centres x,y,z as compared to the reference centre. Such differences were deemed to result in substantial differences in the therapies provided to such patients, based on current treatment recommendations  ADDIN EN.CITE ().
The level of agreement (strength of the kappa coefficient or ICC) can be interpreted in the following manner: 0.01-0.20 slight; 0.21-0.40 fair; 0.41-0.60 moderate; 0.61-0.80 good; 0.81-1.00 excellent, using criteria previously published (). A probability ‘p’ value of less than 0.05 was considered statistically significant. All data were analysed using statistics package for social sciences software version 22 (SPSS v.22, New York, USA). 


Results
Patient cohort and renal biopsy specimens
Of the 58 patient biopsies available three cases were excluded, due to have inadequate biopsy size (n=1) and poor image resolution (n=2) as rated by the nephropathologists at centre x,y or z. Therefore 55 biopsies, from 55 patients, were included in the statistical analysis. As summarized in Table 1, 38 (73%) patients were female and most of White (22/55= 42%) or Black race (18/55 = 35%). The mean+SE of age at the time of the biopsy was 15.5+0.39 years.  There were between 4 and 54 (mean+SE, 16.7+1.29) glomeruli per biopsy.  The mean+SE  LN activity score as reported by the reference centre was 4.23+0.50, the LN chronicity score was 1.81+0.18, and the TIA score was 4.45+0.35. The reference centre reported that there was at least some degree of LN damage (LN chronicity score >0) in 48/55 (87%) of the cases and that all included kidney biopsies showed some tubulointerstitial involvement (TIA index score > 0). As per the reference centre, the greatest proportion of the patients had ISN/RPS Class IV LN (23/55 = 42% of the cohort) and LN-activity (LN activity score > 0) was present 38/55 (69%) of the biopsies.

Level of agreement for scoring LN activity, LN Chronicity and TubuloInterstitial Changes
There was a good level of agreement between centres with regards to the LN-activity score (mean+SE; ICC= 0.69+0.06), with additional details shown in Table 2. Conversely, centres varied substantially in the assessment of LN chronicity. Indeed, there was only fair agreement for the LN-chronicity score (ICC= 0.36+0.09) and the TIA scoring (ICC 0.22+0.09). Many of the individual components of the LN-chronicity index and TIA index differed significantly between raters (see supplementary table). Components that demonstrated better agreement among raters included: glomerular proliferation (endocapillary hypercellularity), cellular crescents, hyaline deposits (wireloops), glomerular sclerosis, and the TIA components, tubulointerstitial cell flattening and tubular macrophages. 

Level of Agreement for ISN/RPS Class Assignment
There was significant variation between the three reporting centres (x, y, z) with a range of kappa values (Table 3).  The overall inter-observer variability between the reference centre and the other centres with regards to the histological class assignment was fair with a kappa score of 0.26+0.12. 
Agreement between ISN/RPS Class Assignment that May Alter Management 
The biopsy findings were categorized into proliferative and non-proliferative disease to assess whether the reported differences between other centres and the reference centre would have influenced treatment. There was fair agreement among sites (kappa= 0.24+0.11). As can be seen in Figure 1, the fair level of agreement was mainly attributed to patients with non-proliferative disease being considered  by the reference centre, as having proliferative disease. 

Discussion
The ISN/RPS Classification superseded the WHO Classification for LN and was aimed at  enhancing the  comparability and agreement in the interpretation of histological features as seen on kidney biopsy. We found that even expert nephropathologists showed considerable variation in their reports of ISN/RPS Class, LN activity and chronicity as well as assessment of the tubulointerstital changes with LN in children. 
One might have expected increased differences among pathologists in their scoring of ISN/RPS Class and associated LN indices in paediatric patients when compared to adults. We did not observe this in the current study as our findings were similar to previously reported adult studies. Indeed, using the ISN/RPS Classification, the inter-observer agreement of five nephropathologists was studied in 126 biopsies (from 87 adult SLE patients) and this group demonstrated similar findings in that 54% of cases had fair levels of agreement (kappa <0.4)  ADDIN EN.CITE (, ). 
The degree of inflammation and class assignment are arguably the most important pieces of information to clinicians and are used to  decide on the intensity of anti-inflammatory therapy for children with LN.  Although we found good agreement for the scoring of the LN-Activity index in this pediatric cohort, this was not the case for tubulointerstitial inflammation or LN Chronicity. We consider this as  highly relevant as TIA features correlate with proteinuria in LN  ADDIN EN.CITE () and both interstitial changes and features of chronicity have been associated with long-term renal outcomes (). Variation in the reports of interstitial and chronic changes from LN put the patient at risk of not receiving the most appropriate therapy and surveillance for residual inflammation, hypertension and proteinuria. Better agreement of pathologists in the scoring of LN activity than LN chronicity has also been reported by Gamba et al () in an adult LN population. However, results of less favorable agreement among pathologists can also be found for LN activity (kappa 0.52), suggesting that our analysis in children are similar to what has been reported in adults with LN (). As such, a UK wide study by Furness et al found the ISN/RPS system to be only fair at distinguishing between active and chronic disease changes with a kappa of 0.33 (). 
Theoretically, poor agreement among a relatively small number of pathologists as assessed in this study could be due to one of them having a completely different approach to LN biopsy scoring than all the others. However, this was not the case. Rather, variation was largely present for all histological features assessed among all of the nephropathologists. Indeed, when assessing the specific features of each index, only a few of the components demonstrated agreement that might be considered acceptable,at levels of >0.4.; these components were glomerular proliferation (endocapillary hypercellularity), cellular crescents and hyaline deposits as features of disease activity and glomerular sclerosis for chronicity. Variation in the agreement based on the various histological components considered of the ISN/RPS classification criteria requires further exploration as the most reproducible features that we found are similar to that described in the study by Grootscholten et al (). It is noted that the reference centre and centre y did appear to have the most similarity with their responses. We are unsure the exact reason for this, the histopathologists did not train in the same centres. As we did not set out to assess the pathologists experience further studies in this area would be needed. 
Kidney biopsies are invasive and costly procedure but are pursued regularly given the lack of surrogate biomarkers and the perceived importance for making therapeutic decisions. Thus our study findings should be of particular concern to pediatricians who are treating children and adolescents with LN because the kidney histology – using the current approach to interpretation - does not seem to provide the objective assessment of the renal status that is envisioned. Our secondary analysis suggests that the disagreement between nephropathologists would have meant that treatment would have been escalated in comparison to the reference centre. Over treatment of patients is as much of a concern as under treatment, given the widespread use of corticosteroids and the toxicity of disease modifying agents. 
Taken together this persistent variation among expert nephropathologist may support the need for more exact definitions of the histological changes that are to be considered in the Classification and grading of kidney biopsies or even the need for a new Classification System.  
In view of these findings, we would propose that nephropathologists provide detailed information not only about ISN/RPS Class but also report on LN-Activity, LN-Chronicity and TIA features (). 
Interestingly, our findings are not unique to SLE, similar studies have been conducted in renal transplant histology (). Furness et al raised the question of who is really ‘correct’ at reporting histological findings and does this really matter at all  ADDIN EN.CITE (). We agree it is difficult to state who is ‘correct’; for the purposes of this study we assumed that the reference centre provided the ‘correct’ report, but variation does matter if it seemingly influences patient treatment and thus has the potential to influence patient prognosis. Certainly for clinical research, a central reading of kidney biopsies appears warranted. 
Limitations of this study include the use of a digital system for reporting the slides. This may have been influenced by the local information technology infrastructure and Internet connectivity, however, the study asked participating nephropathologists to record if the image quality might have influenced their interpretation of histological findings and our sub analysis suggested that imaging quality would not have importantly altered the study results. We do not think that inexperience of the participating nephropathologist was the reason for the smaller than desirable agreement in the interpretation of the LN biopsies. Indeed, all participating professionals had many years of experience and are regarded as local and national experts. The number of glomeruli obtained within our study did not appear to influence our findings either (). 
In summary, at the current time kidney biopsies might not provide the objective assessment hoped for by clinical providers for the staging of renal involvement with LN. Using the current Classification System and its proposed definitions to assess and grade histological changes puts the role of a kidney biopsy as a “gold standard” in considerable doubt and further improvements are required.  
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Figure 1: Lupus nephritis kidney biopsy samples were grouped into proliferative, non-proliferative and class V disease according to the ISN/RPS classification. As illustrated the greatest disagreement appears to be between the non-proliferative cases according to the reference centre, deemed as proliferative in the other centres.  As proliferative disease typically requires additional immunosuppressive treatment, this disagreement would presumably result in escalated treatment in the other centres. 

Table 1: Demographic data and disease features of the Cohort (N=55).
Demographic data	Subgroup	Number (%)
Female (%)		38 (73)
Ethnic group	African American	18 (35)
	White 	3 (6)
	Asian 	3 (6)
	Other 	9 (18)
		
Age at biopsy (years, mean+SE)		15.5+0.39
Disease duration (years, mean+SE)		1.6+0.35
ISN/RPS class	I	0 (0)
	II	14 (25.5)
	III	6 (10.9)
	IV	23 (41.8)
	V	12 (21.8)
LN indices		
LN-Activity index score >1		38/55 (69)
LN-Chronicity index score >1		48/55 (87)
TIA index score >1	 	55/55 (100)



Abbreviations: SE standard error, ISN/RPS International society of nephrology/Renal Pathology Society, LN lupus nephritis, TIA tubulointerstitial activity



Table 2: The level of agreement in reporting the components of the activity, chronicity and tubulointerstitial features of renal biopsies 		between the reference centre and other centres (x, y or z).


Table 3: The level of inter-observer agreement in reporting the histological classification of lupus nephritis renal biopsies between the reference centre and the other centres (x, y or z).







Supplementary Table
The mean scores and statistical difference between the components of the lupus nephritis activity, chronicity and tubulointerstitial index features of the renal biopsies when comparison was made between the reference centre and the other centres (x, y or z).
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